Fourth Generation Agents: Medical Management Guidelines
DEPARTMENT OF DEFENSE WASHINGTON DC WASHINGTON
Pagination or Media Count:
These guidelines were developed as part of ongoing preparedness for all hazards and are intended to support fire, EMS, and hospital staff in the medical management of patients if an incident occurs involving a fourth generation agent FGA, also known as A-series or Novichok nerve agents, such as the one used in the United Kingdom U.K. in 2018. No illicit use or manufacture of an FGA or other nerve agent is known to have occurred in the United States U.S., and there is no known threat of any nerve agent use in the U.S. This document is divided into two sections pages 5-7 include recommendations for fire and EMS responders and pages 8-11 include recommendations for hospital staff, with some repetition between the two. As part of ongoing standard preparedness, jurisdictions should update their existing plans with this information and integrate it into in-service training curricula.
- Weapons Effects (Biological)